Owen Mumford announces verified science-based targets and plans for net zero
Owen Mumford, a global leader in the design, manufacture and advancement of medical devices, has announced its emissions reduction targets through the Science Based Targets initiative (SBTi). The company has set a target to achieve net zero by 2045 (to mirror the UK NHS target) in alignment with the recommendations of the 2015 Paris Agreement.
Using science-based targets, companies can determine how much and how quickly they need to reduce their greenhouse gas (GHG) emissions to prevent the worst effects of climate change. The Science Based Targets initiative (SBTi) sets science-based emissions reduction targets in line with climate science, supporting companies as they mobilise ambitious climate action efforts in the private sector. Over 2,000 companies worldwide have already set their targets.
As part of its sustainability action plan, Owen Mumford has joined the Business Ambition for 1.5°c commitment and is one of the first 1000 global businesses to sign up. Launched in 2019, the initiative asks members to pledge to achieve net zero emissions by the latest 2050 following the United Nations Intergovernmental Panel on Climate Change (IPCC) warning that an increase of 1.5°c in global temperature will have catastrophic effects.
By joining the commitment, Owen Mumford also joins the Race to Zero movement, a collaborative effort of leaders across the globe supporting efforts to achieve zero carbon recovery. Owen Mumford recently became one of the first medical device manufacturers in the world to achieve B Corp certification following the establishment of its sustainability programme in 2014 and formal commitment to the United Nation’s Sustainable Development Goals (SDGs). To formalise the pledge to reduce the environmental impact of its operations, Owen Mumford has now set a science-based target, with its base year as 2015. The company will establish a pathway in 2022, including milestones to mark the achievement of goals and measure its success. The focus will be on Scope 3 emissions, which covers factors such as purchased goods and services, business travel and waste disposal.
Jarl Severn, CEO at Owen Mumford said: “Owen Mumford has been an innovator of medical devices for decades, and we understand the importance of leading by example when it comes to the environment and our impact as a business. Setting a science-based target with the SBTi will hold us accountable and help us to reach our net zero target for 2045. We hope this commitment will inspire other businesses to implement their own sustainability targets and work towards the goal of a carbon neutral future.”
Learn more about the Science Based Targets initiative (SBTi) here.
More in Health
£30m for Oxford scientists to rewrite DNA to cure killer heart...
An injectable cure for inherited heart muscle conditions that can kill young people in the prime of their lives could be available within a few years, after an international team of researchers were announced as the winners of the British Heart Foundation’s Big Beat Challenge.
Tips for managing hay fever symptoms at work
searches around hay fever up 316% in the last seven days according to Google trend data 20% of UK population suffer with hay fever leading provider of anti-allergen air sanitiser shares tips on how to manage symptoms at work With hot weather sending pollen counts through the roof, alongside reports of highly potent ‘super pollen’ […]
Jubilee Surprises for Walfinch Homecare Clients and Carers
It was sweet surprises for clients of Walfinch homecare clients – and for their carers over the Jubilee weekend. Kam Gill, Walfinch Oxford owner and care co-ordinator Sarah Stanbrook were out and about surprising members of their care team with Jubilee cakes, just before they went into clients’ homes, so they could have Jubilee teas […]
From this author
Owen Mumford announces 14M investment in new, state-of-the-art, BREAM-certified premises
Owen Mumford, a global leader in the design, manufacture and advancement of medical devices, today announced that work has started on the build of a brand-new, state-of-the-art production facility in Witney, Oxfordshire, UK.
The green imperative for medical device businesses
The global healthcare system is a large contributor to greenhouse gas emissions, representing 4.4% of the total worldwide footprint.¹ Supply chains occupy a significant share of this contribution. In the UK, for instance, 62% of the National Health Service’s emissions footprint came from the supply chain in 2019.²
Sustainability in the medical device sector: Owen Mumford’s journey to B...
Sustainability in the medical sector. Sustainability is no longer a mere buzzword and is now increasingly a mandatory feature in corporate decision-making.